Today

Agents

Chat

Arena

Discover

More

App

Tango Therapeutics Q2 Basic EPS USD -0.37 - TNGX News | Rallies

Tango Therapeutics Q2 Basic EPS USD -0.37

TNGX•2026-08-11

Quarterly results

Aug. 11 (Reuters) - Tango Therapeutics Q2 operating expenses were USD 59.785 million.

Q2 operating income: USD -59.785 million
Q2 net income: USD -55.341 million
Q2 EPS: USD -0.37

Related News

Stardust Power appoints Ray Rivers to board, names him to audit and compensation committees

SDST•2026-08-11

Revolution Medicines, Inc. <RVMD.O>: Truist Securities raises target price to $231 from $210

RVMD•2026-08-11

Oil pares gains as traders weigh Oman-Iran talks

•

2026-08-11

Syra Health Q2 FY26 swings to profit of $250,242; revenue rises 23% to $2.4 million

SYRA•2026-08-11

Ambiq Q2 FY26 GAAP net loss narrows to $7.12 million; net sales rise 89.7% to $33.9 million year over year

AMBQ•2026-08-11